Zimmer Biomet (ZBH)
(Delayed Data from NYSE)
$108.69 USD
+0.50 (0.46%)
Updated Jul 12, 2024 04:00 PM ET
After-Market: $108.75 +0.06 (0.06%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth C Momentum B VGM
Price, Consensus and EPS Surprise
ZBH 108.69 +0.50(0.46%)
Will ZBH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ZBH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ZBH
3 Generative AI-Based MedTech Stocks to Keep an Eye On
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
ZBH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Zimmer Biomet (ZBH) Advances in GenAI Technology With RevelAi
Zimmer Biomet (ZBH) to Broaden Knee Surgery Line With New Alliance
Other News for ZBH
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2024 Financial Results
Goldman’s top 50 high Sharpe Ratio stocks
Peering Into Zimmer Biomet Holdings's Recent Short Interest
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Zimmer Biomet Expands Board, Welcomes Devdatt Kurdikar